Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease

Abbott's Infinity™ DBS is the first FDA approved directional Deep Brain Stimulation (DBS) system to allow targeting of a specific area of the brain that is critical to motor functions Approximately 60,000 Americans are diagnosed with Parkinson's disease... Devices, Neurology, FDA Abbott, Infinity, Deep Brain Stimulation, Parkinson's Disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news